Format

Send to

Choose Destination
Brain Cogn. 1995 Aug;28(3):297-310.

The use of PET in Parkinson's disease.

Author information

1
Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

Abstract

Activation studies with positron emission tomography (PET) have provided an understanding of the pathophysiology of akinesia and tremor in Parkinson's disease (PD). [18F]6-fluoro-L-dopa (FD)-PET and dopamine receptor imaging by PET can assist in the differential diagnosis of various forms of parkinsonism. FED-PET is capable of detecting subclinical dopaminergic deficits. This allows not only the early or preclinical detection of PD but also the investigation of subclinical lesions of the substantia nigra in PD-related disorders. Longitudinal studies of PD and MPTP induced parkinsonism have provided new insight into the pathogenesis of PD.

PMID:
8546856
DOI:
10.1006/brcg.1995.1259
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center